Notice for alpelisib (Novartis Pharmaceuticals Australia Pty Ltd)
Active ingredients
alpelisib
Date of review outcome
Lapse date
Type
Provisional determination
Therapeutic area
Genetic disorder causing excessive growth of affected tissues